Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of Etranacogene Dezaparvovec (CSL222) in Adolescent Males with Severe or Moderately Severe Hemophilia B

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium France Spain
  • Study on the Safety and Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Adults with Severe or Moderately Severe Hemophilia B and AAV5 Antibodies

    Recruiting

    1 1 1 1
    Investigated drugs:
    Bulgaria Poland
  • Study on the Safety and Effectiveness of REGV131 and LNP1265 for Adults with Hemophilia B

    Recruiting

    1 1
    France Germany Italy Spain
  • Study on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors

    Recruiting

    1 1 1
    Investigated drugs:
    Bulgaria France Greece Italy Lithuania Norway +4
  • Study on Long-Term Safety and Effects of Marstacimab for Patients with Severe Hemophilia A or B, With or Without Inhibitors

    Recruiting

    1 1 1
    Investigated drugs:
    Austria Croatia Czechia Denmark France Germany +3
  • Study on Marstacimab for Children with Severe Hemophilia A or B, With or Without Inhibitors

    Recruiting

    1 1 1
    Investigated drugs:
    Austria Czechia Denmark France Germany Italy +2
  • A study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B

    Not yet recruiting

    1 1 1
    France Germany Greece Italy Spain Sweden
  • Study on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa

    Not yet recruiting

    1 1 1 1
    Bulgaria Croatia Czechia France Hungary Ireland +4
  • Title: Study of gene therapy Etranacogene Dezaparvovec (Hemgenix) in adult patients with moderate to severe Hemophilia B

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Belgium Denmark Germany Ireland The Netherlands Sweden
  • Study on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors

    Not recruiting

    1 1 1
    Investigated drugs:
    Denmark Estonia France Germany Hungary Italy +5